The field of interventional cardiology has made great strides in developing innovative treatments that have changed the lives of heart patients around the world. These are just some of the major advancements in which CRF played a role in the last two decades.
Stents are typically made of a metal mesh and stay in the body permanently. One of the latest developments in interventional cardiology is the bioresorbable stent, made from material that can dissolve or be absorbed into the body. These stents are designed to stay within the body releasing medicine and healing the artery, before dissolving and leaving no permanent implant. The first partially bioresorbable stent was approved by the FDA in late 2015. Other fully bioresorbable stents are currently in clinical trials.